| INOVIO PHARMACEUTICAL INC |
| USA |
| Gesundheit |
| US45773H4092 / A400EJ |
| GBM (Frankfurt) / INO (NASDAQ) |
| FRA:GBM, ETR:GBM, GBM:GR, NASDAQ:INO |
| - |
| https://inovio.com/ |
|
Inovio Pharmaceuticals, Inc. is a biotechnology co..
>Volltext.. |
| 97.57 Mio. EUR |
| 62.78 Mio. EUR |
| 0.15 Mio. EUR |
| -72.86 Mio. EUR |
| -90.84 Mio. EUR |
| -2.17 EUR |
| 8.42 Mio. EUR |
| 30.73 Mio. EUR |
| -74.73 Mio. EUR |
| 0.73 |
| -14.95% |
| 9.14% |
| - |
| - |
| - |
| - |
| INOVIO |
| 12.02.26 |
|